Literature DB >> 16501489

The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population.

F Irie1, H Iso, T Sairenchi, N Fukasawa, K Yamagishi, S Ikehara, M Kanashiki, Y Saito, H Ota, T Nose.   

Abstract

Proteinuria, high serum creatinine, and reduced glomerular filtration rate (GFR) have been associated with increased mortality from cardiovascular disease (CVD) and all causes. However, the combined effect of proteinuria with serum creatinine and GFR on CVD or all-cause mortality has not been well investigated. We conducted a 10-year prospective cohort study of 30,764 men and 60,668 women aged 40-79 years who participated in annual health checkups in 1993. The Cox proportional hazards model was used to estimate the relative risk (RR) after adjusting for age, smoking, and other cardiovascular risk factors. The multivariable RR (95% confidence interval (CI)) of CVD death for positive vs negative proteinuria was 1.38 (1.05-1.79) among men and 2.15 (1.64-2.81) among women. The respective RR for the highest vs lowest creatinine groups (> or = 1.3 vs < or = 0.8 mg/dl for men and > or = 1.1 vs < or = 0.6 mg/dl for women) was 1.56 (1.19-2.04) among men and 2.15 (1.58-2.93) among women. The respective RR for GFR < 60 vs > r = 100 ml/min/1.73 m2 was 1.65 (1.25-2.18) among men and 1.81 (1.39-2.36) among women. For individuals with proteinuria combined by hypercreatininemia or reduced GFR, the risk of CVD death was two-fold higher in men and 4-6-fold higher in women compared to those without proteinuria and with normal creatinine level or GFR. Similar associations were observed for stroke, coronary heart disease, and all-cause mortality. Proteinuria, and hypercreatininemia or reduced GFR and their combination were significant predictors of CVD and all-cause mortality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501489     DOI: 10.1038/sj.ki.5000284

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  83 in total

1.  Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients.

Authors:  Yuya Matsue; Akihiko Matsumura; Masami Abe; Maki Ono; Mie Seya; Tomofumi Nakamura; Ryota Iwatsuka; Akira Mizukami; Masahiko Setoguchi; Wataru Nagahori; Masakazu Ohno; Makoto Suzuki; Yuji Hashimoto
Journal:  Heart Vessels       Date:  2011-12-10       Impact factor: 2.037

Review 2.  Clinical assessment and management of dyslipidemia in patients with chronic kidney disease.

Authors:  Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-06-22       Impact factor: 2.801

3.  Home blood pressure level and decline in renal function among treated hypertensive patients: the J-HOME-Morning Study.

Authors:  Kazuki Ishikura; Taku Obara; Masahiro Kikuya; Michihiro Satoh; Miki Hosaka; Hirohito Metoki; Hidekazu Nishigori; Nariyasu Mano; Masaaki Nakayama; Yutaka Imai; Takayoshi Ohkubo
Journal:  Hypertens Res       Date:  2015-10-29       Impact factor: 3.872

4.  Proteinuria, renal impairment, and death.

Authors:  Jeremy Levy
Journal:  BMJ       Date:  2006-06-17

5.  Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. "Current status and perspective of CKD in Asia": diversity and specificity among Asian countries.

Authors:  Yusuke Tsukamoto; HaiYan Wang; Gavin Becker; Hung-Chun Chen; Dae-Suk Han; David Harris; Enyu Imai; Vivekanand Jha; Philip K T Li; Evan J C Lee; Seiichi Matsuo; Yasuhiko Tomino; Kriang Tungsanga; Kunihiro Yamagata; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2009-03-14       Impact factor: 2.801

6.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

7.  Relationship between lipid profiles and kidney function in patients with type 1 diabetes.

Authors:  N Tolonen; C Forsblom; L Thorn; J Wadén; M Rosengård-Bärlund; M Saraheimo; O Heikkilä; K Pettersson-Fernholm; M-R Taskinen; P-H Groop
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

8.  Geographic difference in the prevalence of chronic kidney disease among Japanese screened subjects: Ibaraki versus Okinawa.

Authors:  Kunitoshi Iseki; Masaru Horio; Enyu Imai; Seiichi Matsuo; Kunihiro Yamagata
Journal:  Clin Exp Nephrol       Date:  2008-10-15       Impact factor: 2.801

9.  Prevalence of chronic kidney disease in the Japanese general population.

Authors:  Enyu Imai; Masaru Horio; Tsuyoshi Watanabe; Kunitoshi Iseki; Kunihiro Yamagata; Shigeko Hara; Nobuyuki Ura; Yutaka Kiyohara; Toshiki Moriyama; Yasuhiro Ando; Shoichi Fujimoto; Tsuneo Konta; Hitoshi Yokoyama; Hirofumi Makino; Akira Hishida; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2009-06-11       Impact factor: 2.801

10.  Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.

Authors:  Toshiharu Ninomiya; Vlado Perkovic; Bastiaan E de Galan; Sophia Zoungas; Avinesh Pillai; Meg Jardine; Anushka Patel; Alan Cass; Bruce Neal; Neil Poulter; Carl-Erik Mogensen; Mark Cooper; Michel Marre; Bryan Williams; Pavel Hamet; Giuseppe Mancia; Mark Woodward; Stephen Macmahon; John Chalmers
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.